UL Solutions Inc. (ULS) Surpasses Q3 Earnings and Revenue Estimates
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- ULS UL Solutions+19.5% 12d
Named in this report.
Indirectly affected
- XLI Industrial Select Sector SPDR+0.5% 30d
Industrial Select Sector SPDR holds the industrials sector that UL Solutions belongs to, so it often moves with news about it.
- IQV IQVIA Holdings+5.8% 15d
IQVIA Holdings is a large industrials company like UL Solutions; big names in a sector often move together.
- INCY Incyte+3.1% 9d
Incyte is a large industrials company like UL Solutions; big names in a sector often move together.
- MEDP Medpace Holdings+10.3% 17d
Medpace Holdings is a large industrials company like UL Solutions; big names in a sector often move together.
- CRL Charles River Laboratories International+17.5% 13d
Charles River Laboratories International is a large industrials company like UL Solutions; big names in a sector often move together.
- ICLR ICON Public-6.3% 11d
ICON Public is a large industrials company like UL Solutions; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ULS | -3.68% | +0.59% | base | +7.03% | +6.19% | +1.47% | +4.78% |
| XLI | -1.06% | +0.22% | base | +0.95% | -0.17% | -4.14% | -4.16% |
| IQV | +5.03% | +6.28% | base | +1.55% | +2.04% | +2.45% | +5.15% |
| INCY | -2.84% | -2.72% | base | -2.01% | +2.40% | -1.71% | -0.26% |
| MEDP | +4.13% | +4.61% | base | +2.49% | +1.37% | -2.08% | +0.90% |
| CRL | +6.07% | +11.13% | base | +3.94% | -3.58% | -7.54% | -0.31% |
| ICLR | -10.86% | +5.12% | base | -0.72% | -1.06% | -1.81% | -0.23% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
UL Solutions Inc. (ULS) Surpasses Q3 Earnings and Revenue Estimates Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| CRL | that day | +3.94% | final price |
| CRL | the next day | -3.58% | final price |
| CRL | two days later | -7.54% | final price |
| CRL | three days later | -0.31% | final price |
| CRL | three days earlier | +11.13% | final price |
| CRL | five days earlier | +6.07% | final price |
| ICLR | that day | -0.72% | final price |
| ICLR | the next day | -1.06% | final price |
| ICLR | two days later | -1.81% | final price |
| ICLR | three days later | -0.23% | final price |
| ICLR | three days earlier | +5.12% | final price |
| ICLR | five days earlier | -10.86% | final price |
| INCY | that day | -2.01% | final price |
| INCY | the next day | +2.40% | final price |
| INCY | two days later | -1.71% | final price |
| INCY | three days later | -0.26% | final price |
| INCY | three days earlier | -2.72% | final price |
| INCY | five days earlier | -2.84% | final price |
| IQV | that day | +1.55% | final price |
| IQV | the next day | +2.04% | final price |
| IQV | two days later | +2.45% | final price |
| IQV | three days later | +5.15% | final price |
| IQV | three days earlier | +6.28% | final price |
| IQV | five days earlier | +5.03% | final price |
| MEDP | that day | +2.49% | final price |
| MEDP | the next day | +1.37% | final price |
| MEDP | two days later | -2.08% | final price |
| MEDP | three days later | +0.90% | final price |
| MEDP | three days earlier | +4.61% | final price |
| MEDP | five days earlier | +4.13% | final price |
| ULS | that day | +7.03% | final price |
| ULS | the next day | +6.19% | final price |
| ULS | two days later | +1.47% | final price |
| ULS | three days later | +4.78% | final price |
| ULS | three days earlier | +0.59% | final price |
| ULS | five days earlier | -3.68% | final price |
| XLI | that day | +0.95% | final price |
| XLI | the next day | -0.17% | final price |
| XLI | two days later | -4.14% | final price |
| XLI | three days later | -4.16% | final price |
| XLI | three days earlier | +0.22% | final price |
| XLI | five days earlier | -1.06% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (jointly held), worth $15,001 - $50,000 on 14 Sep 2026. That is 50 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 8 Sep 2026. That is 56 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Iqvia Holdings (IQV) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 61 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Incyte (INCY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 60 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Charles River Laboratories International (CRL) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Icon (ICLR) (jointly held), worth $15,001 - $50,000 on 14 Aug 2026. That is 81 days before publication. Filed 1 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“UL Solutions Inc. (ULS) Surpasses Q3 Earnings and Revenue Estimates” scores 12 out of 100. The score uses 1 sources.